Goretti Duran - Concepedia

Author

Goretti Duran

Universidade de Santiago de Compostela ORCID

Also Known As

G Duran Piñeiro, G Durán, G. Duran, Giovanna Pessanha Cordeiro, Goretti Duran, Goretti Duran Piñeiro, Goretti Duran-Piñeiro, Goretti Durán Piñeiro, Goretti Durán-Piñeiro

Publications

610

Citations

H-Index

Concepts

All Affiliations

Universidade de Santiago de Compostela Fundación Pública Galega de Medicina Xenómica Complejo Hospitalario Universitario de Santiago Servicio Gallego de Salud Instituto de Investigación Sanitaria de Santiago

About

Goretti Duran is an author at Universidade de Santiago de Compostela specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	381
2	Pathology	2	2	56
3	Pharmacology	2	2	325
4	Engineering	1	1	274
5	Biomedical Engineering	1	1	274

Goretti Duran

Publications

572

Citations

H-Index

Page 1

	Year	Citations
Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients Álvaro Goyanes, Christine M. Madla, Aysha Umerji, International Journal of Pharmaceutics Translational MedicineEngineeringTherapy PreparationExcipientsMedicine	2019	274
Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders Lucía Rodríguez‐Pombo, María José de Castro-López, Paula Sánchez‐Pintos, International Journal of Pharmaceutics	2024	57
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration Ceres Fernández–Rozadilla, Jean‐Baptiste Cazier, Vı́ctor Moreno, The Pharmacogenomics Journal Genome-wide Association StudyOncologyChemoprevention StrategyMedicineColorectal Cancer	2012	51
Use of a Comprehensive Panel of Biomarkers to Predict Response to a Fluorouracil–Oxaliplatin Regimen in Patients with Metastatic Colorectal Cancer María Jesús Lamas, Goretti Duran, Emilia Balboa, Pharmacogenomics	2011	42
Pharmacogenetic Analysis in Neoadjuvant Chemoradiation for Rectal Cancer: High Incidence of Somatic Mutations and their Relation with Response Emilia Balboa, Goretti Duran, María Jesús Lamas, Pharmacogenomics	2010	39
X-Ray Cross-Complementing Group 1 and Thymidylate Synthase Polymorphisms Might Predict Response to Chemoradiotherapy in Rectal Cancer Patients María Jesús Lamas, Goretti Duran, Antonio Gómez, International Journal of Radiation OncologyBiologyPhysics Rectal Cancer PatientsRadiation TherapyMedicineColorectal CancerPathology	2010	35
Impact of <i>CYP2C19</i> Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic‐Pharmacokinetic Prospective Multicenter Study Sara Blanco‐Dorado, Olalla Maroñas, Ana Latorre, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2019	27
The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens María Jesús Lamas, Goretti Duran, Emilia Balboa, Cancer Chemotherapy and Pharmacology OncologyGenetic PolymorphismsGastrointestinal OncologyHuman PolymorphismColorectal Cancer	2012	21
Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum‐based chemoradiotherapy treatment Goretti Duran, Santiago Aguín, Raquel Cruz, Head & Neck	2019	15
Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics? Goretti Duran, Raquel Cruz, Ana Rita Simões, Journal of Chemotherapy	2020	11

Page 1